risperidone has been researched along with Paranoia in 13 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 5.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
| "We report on a 17-year-old girl who developed steatohepatitis and marked weight gain during risperidone treatment for paranoid psychosis." | 5.10 | Risperidone-associated steatohepatitis and excessive weight-gain. ( Bechtinger, E; Holtmann, M; Kopf, D; Mayer, M; Schmidt, MH, 2003) |
| "Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 1.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Dhir, S | 1 |
| Khalid, Z | 1 |
| Salcedo, J | 1 |
| Shanbour, A | 1 |
| Torio, I | 1 |
| Bagney, A | 1 |
| Caballero, M | 1 |
| Jiménez-Arriero, MA | 1 |
| Rodríguez-Jiménez, R | 1 |
| Haeckert, J | 1 |
| Bunse, T | 1 |
| Wirth, S | 1 |
| Hamerle, M | 1 |
| Falkai, P | 1 |
| Hasan, A | 1 |
| Makkos, Z | 1 |
| Fejes, L | 1 |
| Inczédy-Farkas, G | 1 |
| Kassai-Farkas, A | 1 |
| Faludi, G | 1 |
| Lazáry, J | 1 |
| Holtmann, M | 1 |
| Kopf, D | 1 |
| Mayer, M | 1 |
| Bechtinger, E | 1 |
| Schmidt, MH | 1 |
| Englert, I | 1 |
| Duggal, HS | 1 |
| Chouinard, MJ | 1 |
| Nguyen, DK | 1 |
| Clément, JF | 1 |
| Bruneau, MA | 1 |
| De León, OA | 1 |
| Jobe, TH | 1 |
| Furmaga, KM | 1 |
| Gaviria, M | 1 |
| Friedman, JH | 1 |
| Cetin, M | 1 |
| Ebrinç, S | 1 |
| Ağargün, MY | 1 |
| Yiğit, S | 1 |
| Starr, JM | 2 |
1 trial available for risperidone and Paranoia
| Article | Year |
|---|---|
Risperidone-associated steatohepatitis and excessive weight-gain.
Topics: Adolescent; Antipsychotic Agents; Fatty Liver; Female; Humans; Paranoid Disorders; Risperidone; Weig | 2003 |
12 other studies available for risperidone and Paranoia
| Article | Year |
|---|---|
Acetyl-l-Carnitine and New-Onset Psychosis During the COVID-19 Pandemic.
Topics: Acetylcarnitine; Antipsychotic Agents; COVID-19; Delusions; Dietary Supplements; Humans; Male; Middl | 2020 |
[Psychosis due to vitamin B12 deficiency in an elderly patient].
Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Gastritis, Atrophic; Humans; Paranoid Disorders; P | 2014 |
Massive, previously undetected cancer metastasis revealed by application of a depot antipsychotic: a case report.
Topics: Adenocarcinoma, Follicular; Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Magne | 2014 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diben | 2011 |
[Diphenhydramin-overdose: anticholinergic symptoms, EEG-findings in the course and drug treatment of a gerontopsychiatric patient].
Topics: Aged; Brain; Cholinergic Antagonists; Dementia; Depressive Disorder; Diphenhydramine; Drug Therapy, | 2004 |
Cognitive affective psychosis syndrome in a patient with sporadic olivopontocerebellar atrophy.
Topics: Adolescent; Affective Disorders, Psychotic; Anti-Dyskinesia Agents; Antidepressive Agents, Second-Ge | 2005 |
Catatonia induced by levetiracetam.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Catatonia; Drug Therapy, Combination; Epilepsies, Part | 2006 |
Severe extrapyramidal reaction due to risperidone in a case of neurofibromatosis.
Topics: Basal Ganglia Diseases; Brain Neoplasms; Humans; Male; Middle Aged; Neurofibroma; Neurofibromatoses; | 1997 |
Rapid onset tardive dyskinesia ("fly catcher tongue") in a neuroleptically naive patient induced by risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dyskinesia, Drug-Induced; Hum | 1998 |
Risperidone for the treatment of monosymptomatic hypochondriacal psychosis.
Topics: Adult; Antipsychotic Agents; Drug Administration Schedule; Humans; Hypochondriasis; Male; Paranoid D | 1999 |
Treating acquired haemophilia: an ethical conundrum.
Topics: Aged; Antipsychotic Agents; Ethics, Medical; Female; Hemophilia A; Humans; Paranoid Disorders; Rispe | 2000 |
Treating acquired haemophilia: an ethical conundrum.
Topics: Administration, Oral; Aged; Antipsychotic Agents; Clopenthixol; England; Ethics, Medical; Female; He | 2001 |